Singapore, 10 November 2020 – HOYA Surgical Optics, the worldwide leader in preloaded IOL delivery systems, obtained CE Mark for Qube™ pro powered by eyeflexa™, a technology that can support both cataract and vitreoretinal surgery.
eyeflexa™ is a multi-upgrade platform designed to evolve with the changing needs of ophthalmic surgeons. It will be available in 3 configurations – anterior basic, anterior lux, and combined lux. It is designed to be flexible and support surgeons as their expertise and practice demands grow.
“We are very proud to introduce Qube™ pro powered by eyeflexa™, a technology ready to meet our customers’ needs today while being easily upgradable in the future should those needs evolve” explained Antonio Gianno, VP Global Marketing.
HOYA Surgical Optics will now commence the marketing evaluation phase where customers will be able to experience: (1) the performance of eyeflexa™ in both anterior and posterior segment, (2) flexible commercial solutions tailored to their needs, and (3) the highly professional clinical application and technical service support.
HOYA Surgical Optics acquired MID Labs and RUCK in 2019 in order to expand its scope of business and better serve its customers’ needs. The combined capability allows for increased support of cataract surgery as well as the ability to offer customers more comprehensive solutions for their patients.
John Goltermann Lassen, CEO of HOYA Surgical Optics shared “While we remain an IOL-focused company, strategic acquisitions allow us to better serve our customers’ broader needs for high quality ophthalmic products, equipment and services. Based on the acquisition of MID Labs and RUCK, along with investments in R&D, we have been able to bring this new technology to market, strengthen our presence in the equipment space, and complement our core IOL business.”
About HOYA Surgical Optics
With more than 75 years of optical product expertise from the HOYA Group and over 30 years of experience in designing and producing intraocular lenses, HOYA Surgical Optics’ mission is to improve vision and quality of life for millions of people suffering from cataract.
Based on the core tenets of Quality, Trust, Dedication and Attention to Detail, HOYA Surgical Optics develops innovative and high-quality products that offer ease of use, safety and reliability to eye surgeons and ophthalmologists worldwide. HOYA Surgical Optics is the fastest growing IOL company in the world and the global market leader in developing preloaded IOLs. For more information, please visit http://www.hoyasurgicaloptics.com.
HOYA Surgical Optics is a division of HOYA Group.
Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. With an annual revenue of 566 billion yen (FY2018), HOYA is active in the fields of healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels, and hard disk drives. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of 37,000 people. For more information, please visit http://www.hoya.com.
HOYA Surgical Optics